Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Kristiansen

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
BMJ Open|July 18, 2014
Adding liraglutide to the backbone therapy of biguanide in patients with coronary artery disease and newly diagnosed type-2 diabetes (the AddHope2 study): a randomised controlled study protocolChristian Anholm, Preman Kumarathurai, Malene S Klit, et al.
Diabetes, Obesity & Metabolism|November 25, 2025
Assessment of thyroid cancer risk associated with glucagon-like peptide 1 receptor agonist useTina Vilsbøll, Michael Stellfeld, Vanita R Aroda, et al.
Diabetes|July 25, 2000
NeuroD/BETA2 gene variability and diabetes: no associations to late-onset type 2 diabetes but an A45 allele may represent a susceptibility marker for type 1 diabetes among Danes. Danish Study Group of Diabetes in Childhood, and the Danish IDDM Epidemiology and Genetics GroupL Hansen, J N Jensen, S Urioste, et al.
Diabetologia|July 25, 2000
Complete molecular scanning of the human Fas gene: mutational analysis and linkage studies in families with type I diabetes mellitus. The Danish Study Group of Diabetes in Childhood and The Danish IDDM Epidemiology and Genetics GroupR L Nolsøe, O P Kristiansen, K Sangthongpitag, et al.
Diabetes, Obesity & Metabolism|May 4, 2019
Effect of liraglutide on estimates of lipolysis and lipid oxidation in obese patients with stable coronary artery disease and newly diagnosed type 2 diabetes: A randomized trialChristian Anholm, Preman Kumarathurai, Amirsalar Samkani, et al.
Human Molecular Genetics|April 30, 2003
Association of a functional 17beta-estradiol sensitive IL6-174G/C promoter polymorphism with early-onset type 1 diabetes in femalesOle P Kristiansen, Runa L Nolsøe, Lykke Larsen, et al.
Diabetologia|January 13, 2005
Variations of the interleukin-6 promoter are associated with features of the metabolic syndrome in Caucasian DanesY H Hamid, C S Rose, S A Urhammer, et al.
Diabetologia|July 14, 1998
Predictors of IDDM recurrence risk in offspring of Danish IDDM patients. Danish IDDM Epidemiology and Genetics GroupT Lorenzen, F Pociot, L Stilgren, et al.
Ugeskrift for Laeger|March 3, 1999
[Markers for risk of IDDM in children of Danish patients with IDDM. A population-based, historical prospective study]T Lorenzen, F Pociot, L S Stilgren, et al.
Nature Communications|November 23, 2021
A Phase I/II randomized trial of H56:IC31 vaccination and adjunctive cyclooxygenase-2-inhibitor treatment in tuberculosis patientsSynne Jenum, Kristian Tonby, Corina S Rueegg, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
BMJ Open|July 18, 2014
Adding liraglutide to the backbone therapy of biguanide in patients with coronary artery disease and newly diagnosed type-2 diabetes (the AddHope2 study): a randomised controlled study protocolChristian Anholm, Preman Kumarathurai, Malene S Klit, et al.
Diabetes, Obesity & Metabolism|November 25, 2025
Assessment of thyroid cancer risk associated with glucagon-like peptide 1 receptor agonist useTina Vilsbøll, Michael Stellfeld, Vanita R Aroda, et al.
Diabetes|July 25, 2000
NeuroD/BETA2 gene variability and diabetes: no associations to late-onset type 2 diabetes but an A45 allele may represent a susceptibility marker for type 1 diabetes among Danes. Danish Study Group of Diabetes in Childhood, and the Danish IDDM Epidemiology and Genetics GroupL Hansen, J N Jensen, S Urioste, et al.
Diabetologia|July 25, 2000
Complete molecular scanning of the human Fas gene: mutational analysis and linkage studies in families with type I diabetes mellitus. The Danish Study Group of Diabetes in Childhood and The Danish IDDM Epidemiology and Genetics GroupR L Nolsøe, O P Kristiansen, K Sangthongpitag, et al.
Diabetes, Obesity & Metabolism|May 4, 2019
Effect of liraglutide on estimates of lipolysis and lipid oxidation in obese patients with stable coronary artery disease and newly diagnosed type 2 diabetes: A randomized trialChristian Anholm, Preman Kumarathurai, Amirsalar Samkani, et al.
Human Molecular Genetics|April 30, 2003
Association of a functional 17beta-estradiol sensitive IL6-174G/C promoter polymorphism with early-onset type 1 diabetes in femalesOle P Kristiansen, Runa L Nolsøe, Lykke Larsen, et al.
Diabetologia|January 13, 2005
Variations of the interleukin-6 promoter are associated with features of the metabolic syndrome in Caucasian DanesY H Hamid, C S Rose, S A Urhammer, et al.
Diabetologia|July 14, 1998
Predictors of IDDM recurrence risk in offspring of Danish IDDM patients. Danish IDDM Epidemiology and Genetics GroupT Lorenzen, F Pociot, L Stilgren, et al.
Ugeskrift for Laeger|March 3, 1999
[Markers for risk of IDDM in children of Danish patients with IDDM. A population-based, historical prospective study]T Lorenzen, F Pociot, L S Stilgren, et al.
Nature Communications|November 23, 2021
A Phase I/II randomized trial of H56:IC31 vaccination and adjunctive cyclooxygenase-2-inhibitor treatment in tuberculosis patientsSynne Jenum, Kristian Tonby, Corina S Rueegg, et al.
Pageof 6